TITLE

Niacin Beats Ezetimibe Head to Head

PUB. DATE
December 2009
SOURCE
Internal Medicine Alert;12/15/2009 Pharmacology Watch, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a study which examines the impact of statin and niacin on the level of high-density lipoprotein-cholesterol (HDL-C).
ACCESSION #
47878161

 

Related Articles

  • If You're Already on a Statin, Does Adding Niacin Help?  // Neurology Alert;Feb2012 Clinical Brief, p1 

    The article discusses research on the effects of taking niacin as an additional medication in preventing the recurrence of cardiovascular events in patients under statin medication, referencing a study published in a 2011 issue of "The New England Journal of Medicine."

  • Do patients on statins also need niacin? Jones, Kelly W. // JAAPA: Journal of the American Academy of Physician Assistants (;Jul2013, Vol. 26 Issue 7, p9 

    Niacin has been used for years to treat hypercholesterolemia, but may not be as beneficial as thought for patients at high risk of cardiovascular disease. Until further research is done, niacin should be used only in patients who do not tolerate or respond to statin therapy, and never in...

  • Taking lipid-lowering drugs.  // Patient Care;10/15/2001, Vol. 35 Issue 19, p56 

    Provides information on different lipid-lowering drugs to prevent cardiovascular disease. Recommended dosage of resins; Discussion on statins; Physiological effects of niacin.

  • The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins? Anfossi, Giovanni; Trovati, Mariella // Current Drug Therapy;Sep2007, Vol. 2 Issue 3, p177 

    The Metabolic Syndrome is commonly associated with an atherogenic dyslipidemia which accounts for a high risk of atherothrombosis and cardiovascular events. The fundamental defect of patients with the Metabolic Syndrome is the resistance to insulin action which is involved in the appearance of a...

  • Which is the Culprit: The Drug or the Vitamin?  // Positive Health;Apr2013, Issue 205, p1 

    The article discusses the health benefits of the essential nutrient niacin. It mentions the tredaptive drug trial, the components of which include niacin and another drug called laropripant, and the trial's implications that niacin causes health problems. It is argued that niacin has been widely...

  • DRUG NEWS. Goodman, Brenda // Arthritis Today;Mar/Apr2010, Vol. 24 Issue 2, p45 

    The article offers news briefs related to drugs. A study found that an experimental form of the corticosteroid prednisone may relieve morning stiffness relief in people with rheumatoid arthritis (RA). The Biologic drug belimumab (Benlysta) for lupus therapy is seeking approval from the U.S. Food...

  • Niacin-laropiprant adjunct to statin therapy poses risks to heart patients, study says. Talsma, Julia // Drug Topics;Aug2014, Vol. 158 Issue 8, p25 

    The article presents the results of a study on the risk of niacin-laropiprant therapy in treating vascular heart disorders of patients in the U.S. Researchers did a four-year study on greater than 25,000 patients who randomly received either placebo or combination of laropiprant and...

  • Niacin added to statin therapy does not improve treatment of cardiovascular disease.  // Australian Journal of Pharmacy;Jul2012, Vol. 93 Issue 1106, p88 

    The article reports that the inclusion of the drug niacin with statin therapy does not improve the treatment outcome of cardiovascular diseases. INSET: A\vailable in Australia.

  • Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia: The OCEANS Study. Karas, Richard H.; Kashyap, Moti L.; Knopp, Robert H.; Keller, Laurence H.; Bajorunas, Daiva R.; Davidson, Michael H. // American Journal of Cardiovascular Drugs;2008, Vol. 8 Issue 2, p69 

    Introduction: High-dose HMG-CoA reductase inhibitors (statins) fail to prevent approximately two-thirds of cardiovascular events. This fact has focused increased attention on treating abnormalities of non-high-density lipoprotein-cholesterol (non-HDL-C), HDL-C, and triglycerides in national...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics